Filgrastim Unknown Status Phase 3 Trials for Myelodysplastic Syndrome

IndicationsStatusPurposePhase
Unknown StatusNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT01196715Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes